dictamnine has been researched along with Lung Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, S; Guo, X; Hao, P; Peng, J; Wang, J; Ward, R; Xiang, C; Xu, TR; Yang, Y; Yu, J; Zhang, L; Zhang, N | 1 |
| An, FF; Liang, L; Liu, YC; Zhang, WW | 1 |
2 other study(ies) available for dictamnine and Lung Neoplasms
| Article | Year |
|---|---|
Dictamnine, a novel c-Met inhibitor, suppresses the proliferation of lung cancer cells by downregulating the PI3K/AKT/mTOR and MAPK signaling pathways.
Topics: A549 Cells; Animals; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Female; Hep G2 Cells; Humans; Lung Neoplasms; MAP Kinase Signaling System; Mice, Inbred BALB C; Mice, Nude; Phosphatidylinositol 3-Kinases; Phosphotransferases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-met; Quinolines; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2022 |
Dihydroartemisinine enhances dictamnine-induced apoptosis via a caspase dependent pathway in human lung adenocarcinoma A549 cells.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Apoptosis; Artemisinins; Caspase 3; Cell Death; Cell Line, Tumor; Drug Synergism; Humans; Lung Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Quinolines; S Phase Cell Cycle Checkpoints; Signal Transduction | 2013 |